The Syneos Health Podcast: Conversations on Commercialization
tekijä: Syneos Health
Moving Beyond AI Hype to Measurable Commercial Impact
Tietoa podcastista
Commercialization is becoming more tightly connected to decisions across the biopharma journey, from value and access to launch strategy, deployment and patient, provider and advocacy engagement. Conversations on Commercialization is the latest addition to the Syneos Health Podcast family, featuring leaders and experts from across the industry discussing the strategies, challenges and shifts shaping commercial success in today’s market.
Each episode explores how companies are approaching the issues that matter most in commercialization and what it takes to compete more effectively in today’s market.
Subscribe to The Syneos Health Podcast: Conversations on Commercialization for new episodes.
If there’s a topic you’d like us to explore, send us a message at [email protected].
For more actionable, future-focused life sciences insights, visit the Syneos Health Insights Hub.
Jaksot
Uusimmat 20 jaksoa 22 jaksosta
- Moving Beyond AI Hype to Measurable Commercial Impact · 20 minIn this episode of The Syneos Health Podcast: Conversations on Commercialization, Commercial VP and Host, Tyler Cowan, speaks with Tim Jones, SVP, Commercial Excellence and…
- Everybody Wins: Elevating the Patient Voice · 28 minIn this episode of The Syneos Health Podcast: Conversations on Commercialization, Tyler Cowan, VP, Commercial is joined by colleagues from our team in the UK, Dr. Natalia…
- AI With Accountability: How Small Biopharma Can Scale Smarter · 17 minIn this episode, recorded on the ground at Asembia's AXS26 Summit, host Chris Van Denburg sits down with George Jones, Chief Commercial Officer at Biofrontera, to explore how…
- Reducing Friction in CAR T Care: Patient Support for Speed, Scale and Better Outcomes · 22 minAt the Asembia 2026 Summit, Syneos Health host Chris Van Denburg sits down with Dale Lippert, Executive Director, CAR T Patient Support and Services at Autolus Therapeutics, to…
- Beyond the Traditional Commercial Model: Insights from Asembia 2026 · 18 minRecorded from the floor of Asembia 2026, this episode explores how biopharma leaders are rethinking reimbursement, patient access and commercial strategy in an increasingly…
- Connected Care, Better Outcomes: Rethinking the Future of Patient Support · 17 minRecorded on the ground at the Asembia Summit 2026, this episode explores how stronger collaboration, connected care models and patient-centered listening can improve access…
- AI Coaching for Pharma Field Forces: Reviewing the Game Tape with KAI Conversations · 20 minIn this episode of Conversations on Commercialization, host Michael Sarshad, Managing Director, Consulting at Syneos Health, talks with KAI CEO David Williams and Deanne Melloy…
- Navigating Dermatology’s New Access Landscape with Paul Rittman of Almirall US · 23 minIn this episode, Tyler Cowan, VP, Commercial speaks with Paul Rittman, President and General Manager of Almirall US, about how payer consolidation and PBM influence are reshaping…
- Changing the Name Game with Addison Whitney’s Ari™ · 20 minWhat if drug naming could be faster, smarter and more aligned to brand strategy? In this episode, Addison Whitney’s Joe Daley, President, and Bill Purdy, SVP and Managing…
- DTP, AI and the Future of Pharma Access · 15 minRecorded at Fierce Pharma Week 2025, the conversation continues with part two of our conversation with Mark Bard, co-founder of the Digital Health Coalition. In this episode…
- The New Rules of HCP Engagement · 20 minRecorded at Fierce Pharma Week 2025, here is the first episode in a two-part series with Mark Bard, co-founder of the Digital Health Coalition. In this episode, Bard joins host…
- GLP-1 Gold Rush — Who’s Really Winning in the New Obesity Market? · 18 minHost Tyler Cowan, VP Commercial at Syneos Health, joins Hruta Shah, Senior Engagement Manager for Syneos Health Consulting, to break down the high-stakes race in obesity…
- Redefining Access for Enhanced Retail Therapies, with Cheryl Allen of Curatio Advisors · 10 minIn this episode, host Sara Rubin is joined by Cheryl Allen, RPh, founding partner at Curatio Advisors, to explore how manufacturers can evolve their access strategies in response…
- Navigating Modern Market Access · 13 minThe biopharma market is booming—but not without turbulence. In this kickoff episode of our special podcast series in collaboration with Asembia, hosts Michael Sarshad, Managing…
- Reimagining Patient Support: Scaling Access, Affordability and AI Integration with Kelly Carter of Amgen · 19 minRecorded from the floor of Asembia’s AXS25 Summit, host Michael Sarshad sits down with Kim Plesnarski, SVP of Market Access and Patient Support Services at Syneos Health and…
- Modernizing Patient Services: AI, Hybrid Models and Innovation Strategy with Greg Morris of CareMetx · 29 minIn this special edition of the Syneos Health Podcast recorded from the floor of Asembia’s AXS25 Summit, host Michael Sarshad speaks with Kim Plesnarski, SVP of Market Access and…
- Holistic Patient Support with Tiara Green of Accessia Health · 10 minIn this special episode recorded from the floor at Asembia’s AXS25 Summit, host Michael Sarshad sits down with Tiara Green, President of Accessia Health, to explore the evolving…
- Redefining Market Access: Patient Support, Technology and Pharma Strategy with Rob Truckenmiller of PharmaCord · 10 minIn this episode of our Navigating Modern Market Access series, recorded from the floor of Asembia's AXS25 Summit, host Sara Rubin sits down with Rob Truckenmiller, the newly…
- 2025 Health Trends | Getting Real About Omnichannel: A View from the Leading Edge · 35 minHosted by Drew Beck, Head of Strategy, Growth and Innovation for Syneos Health Learning Solutions, this limited series dives into the breakthrough trends redefining health in…
- 2025 Health Trends | AI as an R&D Investment · 24 min2025 Health Trends meets The Syneos Health Podcast for a limited series exploring how Trends come alive in the life sciences industry with host Drew Beck, Head of Strategy…








